ADVM:Adverum Biotechnologies Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
$10.70
EXCHANGE
NASDAQ
SECTOR
Health Care
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
52-Week Low/High Stock Price$2.81 - $16.38
Percent Held by Institutions10.63%
Revenue$570,000
Net Income$-77,338,000
Cash Flow$-9,530,000
EPS-0.25%
Market Cap$691,091,600
PE Ratio to Industry46%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.33%
Total Return Last 12 Months189.97%
Total Return Last 3 Years234.38%
Total Return Last 5 Years-78.56%
Latest Trade DateDec. 11, 2019
No Data available for Payment History.
Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. Co. develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Co.'s main capabilities include clinical development, vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control. Co. is conducting a clinical trial for its gene therapy candidate ADVM-022, AAV.7m8-aflibercept, for the treatment of wet age-related macular degeneration.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Oct. 15, 2019CLOSE PRICE INCREASE: Adverum Biotechnologies Inc (NASDAQ: ADVM) on 10-15-2019 increased close price > 10% from $5.29 to $6.09
Read more...Sep. 24, 2019CLOSE PRICE DECREASE: Adverum Biotechnologies Inc (NASDAQ: ADVM) on 09-24-2019 decreased close price > 10% from $6.44 to $5.77
Read more...Sep. 13, 2019CLOSE PRICE DECREASE: Adverum Biotechnologies Inc (NASDAQ: ADVM) on 09-13-2019 decreased close price > 10% from $12.00 to $5.96
Read more...Dec. 12, 2019DIVIDEND RATE INCREASE: Amgen Inc (NASDAQ: AMGN) on 12-12-2019 increased dividend rate > 3% from $5.80 to $6.40
Read more...Dec. 12, 2019CLOSE PRICE INCREASE: Genenews Ltd (OTCBB: GNWSF) on 12-12-2019 increased close price > 10% from $0.03 to $0.03
Read more...Dec. 12, 2019CLOSE PRICE DECREASE: Harbor Diversified Inc (OTCBB: HRBR) on 12-12-2019 decreased close price > 10% from $0.04 to $0.03
Read more...